183 results on '"Witteveen, Petronella O."'
Search Results
2. Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.
3. Functional decline after surgery in older patients with head and neck cancer
4. PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer
5. Validation of the G8 screening tool in older patients with cancer considered for surgical treatment
6. The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: A systematic review and meta-analysis
7. Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)
8. Predicting Anxiety in Hospitalized Cancer Patients
9. Predictive value of each geriatric assessment domain for older patients with cancer: A systematic review
10. Pan-cancer whole-genome analyses of metastatic solid tumours
11. Use of a Symptom Diary on Oncology Wards: Effect on Symptom Management and Recommendations for Implementation
12. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
13. Supplementary Table 1 and 2 from First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies
14. Data from A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
15. Supplementary Figures 1-3 from A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
16. The association between patient satisfaction with information and adherence to oral anticancer agents
17. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy
18. Response to Systemic Therapies in Ovarian Adult Granulosa Cell Tumors: A Literature Review
19. Frailty and checkpoint inhibitor toxicity in older patients with melanoma
20. Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer
21. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience
22. sj-docx-1-opp-10.1177_10781552221077258 - Supplemental material for The association between patient satisfaction with information and adherence to oral anticancer agents
23. sj-docx-3-opp-10.1177_10781552221077258 - Supplemental material for The association between patient satisfaction with information and adherence to oral anticancer agents
24. sj-docx-2-opp-10.1177_10781552221077258 - Supplemental material for The association between patient satisfaction with information and adherence to oral anticancer agents
25. Semi-automatic software increases CT measurement accuracy but not response classification of colorectal liver metastases after chemotherapy
26. A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
27. The association between patient satisfaction with information and adherence to oral anticancer agents
28. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
29. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study
30. [18F]FDG and [18F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary
31. Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
32. Development and testing of a tailored online fertility preservation decision aid for female cancer patients
33. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome
34. Validation of the Dutch version of the Edmonton Symptom Assessment System
35. Distinct genomic profiles are associated with treatment response and survival in ovarian cancer
36. Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses
37. Specialized Care and Survival of Ovarian Cancer Patients in The Netherlands: Nationwide Cohort Study
38. Use of a Symptom Diary on Oncology Wards: Effect on Symptom Management and Recommendations for Implementation.
39. Development and testing of a tailored online fertility preservation decision aid for female cancer patients.
40. Patients’ Needs Regarding Anxiety Management in Palliative Cancer Care: A Qualitative Study in a Hospice Setting
41. The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer
42. Pan-cancer whole genome analyses of metastatic solid tumors
43. Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy.
44. The predictive value of symptoms for anxiety in hospice inpatients with advanced cancer
45. Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma
46. Next-Generation Sequencing in Gynaecological Tumours: The Prognostic and Predictive Value of the Most Common Mutations Found in Ovarian, Endometrial, and Cervical Tumours: Literature Review and the University Medical Centre Utrecht Next-Generation Sequencing Data
47. Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function
48. A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
49. The predictive value of symptoms for anxiety in hospice inpatients with advanced cancer.
50. First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.